8-K - Starling Oncology, Inc. (0001799191) (Filer)
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Starling Oncology filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- STLN Starling Oncology
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Starling Oncology belongs to, so it often moves with news about it.
- HIMS Hims & Hers Health-8.9% 30d
Hims & Hers Health is a peer of Starling Oncology in offices and clinics of doctors of medicine; rivals often move on the same news.
- HCA HCA Healthcare+20.6% 30d
HCA Healthcare is a large health company like Starling Oncology; big names in a sector often move together.
- NTRA Natera-0.5% 30d
Natera is a large health company like Starling Oncology; big names in a sector often move together.
- LH Labcorp Holdings+19.1% 30d
Labcorp Holdings is a large health company like Starling Oncology; big names in a sector often move together.
- DGX Quest Diagnostics+8.1% 30d
Quest Diagnostics is a large health company like Starling Oncology; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| STLN | -2.47% | -5.23% | base | after close | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | after close | after close | after close | after close |
| HIMS | +15.07% | +6.94% | base | after close | after close | after close | after close |
| HCA | -6.75% | -8.77% | base | after close | after close | after close | after close |
| NTRA | +13.85% | +6.81% | base | after close | after close | after close | after close |
| LH | -0.36% | -2.53% | base | after close | after close | after close | after close |
| DGX | -1.10% | -3.12% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001079973-26-001430 Size: 501 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
This story
| Company | When | Move | Status |
|---|---|---|---|
| DGX | three days earlier | -3.12% | final price |
| DGX | five days earlier | -1.10% | final price |
| HCA | three days earlier | -8.77% | final price |
| HCA | five days earlier | -6.75% | final price |
| HIMS | three days earlier | +6.94% | final price |
| HIMS | five days earlier | +15.07% | final price |
| LH | three days earlier | -2.53% | final price |
| LH | five days earlier | -0.36% | final price |
| NTRA | three days earlier | +6.81% | final price |
| NTRA | five days earlier | +13.85% | final price |
| STLN | three days earlier | -5.23% | final price |
| STLN | five days earlier | -2.47% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Congressional trades in the stocks in this story
- Sen. Richard Blumenthal sold Starling Oncology (STLN) (held by a spouse), worth $1,001 - $15,000 on 23 Sep 2026. That is 43 days before publication. Filed 26 Oct 2026. View the filing.
- Sen. Richard Blumenthal sold Starling Oncology (STLN) (held by a spouse), worth $1,001 - $15,000 on 22 Sep 2026. That is 44 days before publication. Filed 26 Oct 2026. View the filing.
- Sen. Richard Blumenthal sold Starling Oncology (STLN) (held by a spouse), worth $15,001 - $50,000 on 22 Sep 2026. That is 44 days before publication. Filed 26 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Labcorp Holdings (LH) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $100,001 - $250,000 on 25 Aug 2026. That is 72 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $1,001 - $15,000 on 7 Aug 2026. That is 90 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Quest Diagnostics (DGX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “8-K - Starling Oncology, Inc. (0001799191) (Filer)” looks
12 out of 100
“8-K - Starling Oncology, Inc. (0001799191) (Filer)” scores 12 out of 100. The score uses 1 sources.